Marion McCourt - Feb 1, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/** Marion McCourt
Stock symbol
REGN
Transactions as of
Feb 1, 2022
Transactions value $
-$264,530
Form type
4
Date filed
2/2/2022, 03:14 PM
Previous filing
Jan 5, 2022
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $343K +1K +5.09% $342.93 20.6K Feb 1, 2022 Direct F1
transaction REGN Common Stock Sale -$607K -1K -4.84% $607.46 19.6K Feb 1, 2022 Direct F1
holding REGN Common Stock 116 Feb 1, 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1K -11.11% $0.00 8K Feb 1, 2022 Common Stock 1K $342.93 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.